Listen to How "Jazz Remix" Fosters a Positive Employee Experience at Jazz Pharmaceuticals
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Jazz Pharmaceuticals' Chief People Officer discusses the innovative work model 'Jazz Remix' on the Future of HR Podcast, emphasizing flexible work environments and positive employee experiences.
Positive
- None.
Negative
- None.
NORTHAMPTON, MA / ACCESSWIRE / February 13, 2024 / Jazz Pharmaceuticals
Originally published on LinkedIn
Jazz Pharmaceuticals' Chief People Officer Heidi Manna recently appeared on an episode of the Future of HR Podcast where she discussed our innovative work model, "Jazz Remix." Hear her perspective on flexible work environments and how to foster a positive employee experience.
Listen to the discussion of Jazz's innovative and flexible work model here.
View additional multimedia and more ESG storytelling from Jazz Pharmaceuticals on 3blmedia.com.
Contact Info:
Spokesperson: Jazz Pharmaceuticals
Website: https://www.3blmedia.com/profiles/jazz-pharmaceuticals
Email: info@3blmedia.com
SOURCE: Jazz Pharmaceuticals
View the original press release on accesswire.com
FAQ
What did Jazz Pharmaceuticals' Chief People Officer discuss on the Future of HR Podcast?
Heidi Manna discussed Jazz Pharmaceuticals' innovative work model 'Jazz Remix'.
What is the focus of Jazz Pharmaceuticals' work model 'Jazz Remix'?
The focus is on flexible work environments and fostering a positive employee experience.
Where can the discussion of Jazz's work model be heard?
The discussion can be heard on the Future of HR Podcast.
Where can additional multimedia and ESG storytelling from Jazz Pharmaceuticals be found?
Additional multimedia and ESG storytelling can be found on 3blmedia.com.
Jazz Pharmaceuticals, Inc.
NASDAQ:JAZZ
JAZZ Rankings
JAZZ Latest News
May 1, 2024
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Apr 30, 2024
Jazz Pharmaceuticals Focuses on Taking Actions To Positively Impact the Planet This Earth Month
JAZZ Stock Data
6.93B
60.45M
2.82%
95.89%
5.23%
Pharmaceutical Preparation Manufacturing
Manufacturing
United States of America
DUBLIN
About JAZZ
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni